L
Lisa Tjosvold
Researcher at University of Alberta
Publications - 25
Citations - 4519
Lisa Tjosvold is an academic researcher from University of Alberta. The author has contributed to research in topics: Randomized controlled trial & Melatonin. The author has an hindex of 22, co-authored 25 publications receiving 4124 citations.
Papers
More filters
Meditation practices for health: state of the research.
Maria B. Ospina,Kenneth Bond,Mohammad Karkhaneh,Lisa Tjosvold,Ben Vandermeer,Yuanyuan Liang,Liza Bialy,Nicola Hooton,Nina Buscemi,Donna M Dryden,Terry P. Klassen +10 more
TL;DR: Scientific research on meditation practices does not appear to have a common theoretical perspective and is characterized by poor methodological quality, and firm conclusions on the effects of meditation practices in healthcare cannot be drawn based on the available evidence.
Journal ArticleDOI
Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis
Nina Buscemi,Ben Vandermeer,Nicola Hooton,Rena Pandya,Lisa Tjosvold,Lisa Hartling,Sunita Vohra,Terry P. Klassen,Glen B. Baker +8 more
TL;DR: There is no evidence that melatonin is effective in treating secondary sleep disorders or sleep disorders accompanying sleep restriction, such as jet lag and shiftwork disorder, and there is evidence thatmelatonin is safe with short term use.
Journal ArticleDOI
Glucocorticoids for acute viral bronchiolitis in infants and young children.
Ricardo M. Fernandes,Liza Bialy,Ben Vandermeer,Lisa Tjosvold,Amy C Plint,Hema Patel,David W. Johnson,Terry P. Klassen,Lisa Hartling +8 more
TL;DR: Current evidence does not support a clinically relevant effect of systemic or inhaled glucocorticoids on admissions or length of hospitalisation, but combined dexamethasone and epinephrine may reduce outpatient admissions, but results are exploratory and safety data limited.
Journal ArticleDOI
The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.
Nina Buscemi,Ben Vandermeer,Nicola Hooton,Rena Pandya,Lisa Tjosvold,Lisa Hartling,Glen B. Baker,Terry P. Klassen,Sunita Vohra +8 more
TL;DR: There is evidence to suggest that melatonin is not effective in treating most primary sleep disorders with short-term use (4 weeks or less); however, additional large-scale RCTs are needed before firm conclusions can be drawn.
Journal ArticleDOI
Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review.
Maria B. Ospina,Jennifer Seida,Brenda Clark,Mohammad Karkhaneh,Lisa Hartling,Lisa Tjosvold,Ben Vandermeer,Veronica Smith +7 more
TL;DR: It is suggested that Lovaas may improve some core symptoms of ASD compared to special education, but these findings are based on pooling of a few, methodologically weak studies with few participants and relatively short-term follow-up.